Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancer
This study will be inspiring future prospective studies.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Clinical Reports Source Type: research
More News: Calcium | Cancer | Cancer & Oncology | Hypertension | Lung Cancer | Non-Small Cell Lung Cancer | PET Scan | Statistics | Study | Tarceva